156 related articles for article (PubMed ID: 6180542)
1. Transient rise in tumor marker after initial adjuvant chemotherapy for testicular cancer.
Wolf DJ; Williams JJ
Urology; 1982 Jul; 20(1):50-2. PubMed ID: 6180542
[No Abstract] [Full Text] [Related]
2. Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
van der Gaast A; Hoekstra JW; Croles JJ; Splinter TA
J Urol; 1991 Apr; 145(4):829-31. PubMed ID: 1706441
[TBL] [Abstract][Full Text] [Related]
3. [Progress in the therapy of testicular teratoid tumors].
Seeber S
Wien Med Wochenschr; 1982 Jul; 132(13-14):329-33. PubMed ID: 6182701
[TBL] [Abstract][Full Text] [Related]
4. Prognosis following chemotherapy for metastatic malignant teratoma.
Horwich A; Easton D; Husband J; Nicholas D; Peckham MJ
Br J Urol; 1987 Jun; 59(6):578-83. PubMed ID: 2446691
[TBL] [Abstract][Full Text] [Related]
5. Serum tumour marker regression rate following chemotherapy for malignant teratoma.
Horwich A; Peckham MJ
Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1463-70. PubMed ID: 6209145
[TBL] [Abstract][Full Text] [Related]
6. Benign intracranial hypertension during chemotherapy for testicular teratoma.
Marsh LF; Morgan DA; Jefferson D
Br J Radiol; 1988 Aug; 61(728):692. PubMed ID: 2458158
[No Abstract] [Full Text] [Related]
7. [A case of advanced testicular seminoma--chemotherapy and serum marker].
Nakamura K; Hagiwara M; Aikawa A; Deguchi N; Tazaki H; Takeshita E; Ito S
Gan No Rinsho; 1983 Dec; 29(15):1779-82. PubMed ID: 6199531
[TBL] [Abstract][Full Text] [Related]
8. Pre-, per- and post-chemotherapy tumour markers in very advanced testicular cancer.
Fossa SD; Paus E
Prog Clin Biol Res; 1985; 203():121. PubMed ID: 2421325
[No Abstract] [Full Text] [Related]
9. [Case report of a non-seminomatous testicular neoplasm indicating marked efficacy of a combination chemotherapy of VBL, ACTD, BLM, CDDP and EX (VAB-4 combination therapy)].
Hayashi M; Ebihara K; Urano E
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2775-7. PubMed ID: 6210063
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of disseminated seminoma.
Einhorn LH; Williams SD
Cancer Clin Trials; 1980; 3(4):307-13. PubMed ID: 6159120
[TBL] [Abstract][Full Text] [Related]
11. Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
Skinner DG; Scardino PT
Trans Am Assoc Genitourin Surg; 1979; 71():31-5. PubMed ID: 94715
[No Abstract] [Full Text] [Related]
12. Transient tumor marker elevation following chemotherapy for germ cell tumors of the testis.
Horwich A; Peckham MJ
Cancer Treat Rep; 1986 Nov; 70(11):1329-31. PubMed ID: 2429765
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
Stevens MJ; Norman AR; Dearnaley DP; Horwich A
J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
[TBL] [Abstract][Full Text] [Related]
14. High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group.
Stoter G; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; Jones WG; van Oosterom AT; Vendrik CP; Spaander P; de Pauw M; Sylvester R
J Clin Oncol; 1986 Aug; 4(8):1199-206. PubMed ID: 2426419
[TBL] [Abstract][Full Text] [Related]
15. [Tumor markers as a prognostic factor of the response to treatment in cancer of the testicle].
Germa Lluch JR; Bastus Piulats R
Actas Urol Esp; 1987; 11(3):293-8. PubMed ID: 2444075
[No Abstract] [Full Text] [Related]
16. [Limitations of tumor marker surveillance after chemotherapy in advanced non-seminomatous testicular tumors].
Behrendt H; Ringert RH; Pfeiffer R; Homann W; Hartung R
Urol Int; 1983; 38(5):307-9. PubMed ID: 6195793
[TBL] [Abstract][Full Text] [Related]
17. Second malignancy after cisplatin, vinblastine, and bleomycin (PVB) chemotherapy: a case report.
Mead GM; Green JA; Macbeth FR; Williams CJ; Whitehouse JM; Buchanan R
Cancer Treat Rep; 1983 Apr; 67(4):410. PubMed ID: 6189603
[No Abstract] [Full Text] [Related]
18. Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction.
Einhorn LH; Williams SD; Mandelbaum I; Donohue JP
Cancer; 1981 Aug; 48(4):904-8. PubMed ID: 6168361
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of patients in whom germ cell tumour masses enlarged on chemotherapy while their serum tumour markers decreased.
Tonkin KS; Rustin GJ; Wignall B; Paradinas F; Bennett M
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1739-43. PubMed ID: 2483686
[TBL] [Abstract][Full Text] [Related]
20. Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
Vogelzang NJ; Lange PH; Goldman A; Vessela RH; Fraley EE; Kennedy BJ
Cancer Res; 1982 Nov; 42(11):4855-61. PubMed ID: 6181870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
